Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Colorcon
Moodys
Express Scripts
Merck

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Drug Price Trends for XTAMPZA ER

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for XTAMPZA ER

Average Pharmacy Cost for XTAMPZA ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
XTAMPZA ER 36 MG CAPSULE 24510-0140-10 13.68134 EACH 2019-10-23
XTAMPZA ER 13.5 MG CAPSULE 24510-0115-10 6.29569 EACH 2019-10-23
XTAMPZA ER 18 MG CAPSULE 24510-0120-10 7.96915 EACH 2019-10-23
XTAMPZA ER 9 MG CAPSULE 24510-0110-10 4.28281 EACH 2019-10-23
XTAMPZA ER 27 MG CAPSULE 24510-0130-10 11.09559 EACH 2019-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Medtronic
McKesson
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.